Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ola Elrouby"'
Autor:
Kamal Hussein, Ahmed F. Ahmed, Magda M.A. Omar, Rania A. Galhom, Mostafa Salah, Ola Elrouby, Yasser Nassar
Publikováno v:
Heliyon, Vol 8, Iss 9, Pp e10736- (2022)
Background: In response to COVID-19 global crisis and arising from social responsibility, efforts have been exerted to promptly research, develop and manufacture ICU ventilators locally to meet the spike in demand. This study aimed at: Evaluating the
Externí odkaz:
https://doaj.org/article/5b60509b3cdb4fe0a4d33f09194a0896
Autor:
Mostafa Yakoot, Basem Eysa, Essam Gouda, Sherine A Helmy, Mahmoud R Elsayed, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A Zidan, Abd-Elmoniem Adel, Mohamed Hassany
BACKGROUNDPreliminary data suggests a potential therapeutic benefit for the hepatitis C drugs, sofosbuvir (SOF) and daclatasvir (DCV) for the treatment of COVID-19. We aim to evaluate efficacy of a short course of dual sofosbuvir/daclatasvir in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10bd2cd61fd38ab33556877044a48064
https://doi.org/10.1101/2022.07.18.22277477
https://doi.org/10.1101/2022.07.18.22277477
Autor:
Sherif Abbass, Eman El-hosieny, Mohamed Elgazzar, El-Sayed Tharwa, Ismail Shehab, Tary Salman, Doaa Mahdi, Ehab Kamal, Imam Waked, Mahmoud Farouk, Mohsen Salama, Ola Elrouby, Wael Abdel-Razek, Ahmed Abdelgwad, Sherine Helmy, Neamt Sakr, Mai Mansour, Mounir Saif, Mohamed Einar, Mostafa Salah, Alyaa Sabry
Publikováno v:
Journal of Medical Virology
Only a few treatments are approved for coronavirus disease‐2019 (COVID‐19) infections, with continuous debate about their clinical impact. Repurposing antiviral treatments might prove the fastest way to identify effective therapy. This trial aime